The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews

, , , , Yu, K., , de Abreu Alves, F., Ashbury, F. D., Eng, L., Fitch, M., Jain, H., Jefford, M., Klemanski, D., Koczwara, B., Loh, K., Prasad, M., Rugo, H., Soto-Perez-de-Celis, E., van den Hurk, C., Chan, A., & other, and (2021) The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews. Annals of Oncology, 32(12), pp. 1552-1570.

Free-to-read version at publisher website

Description

Highlights
• Telemedicine interventions can be effective for addressing the psychosocial and physical effects of cancer.
•Development of evidence-based guidance for the implementation of telemedicine in survivorship care is urgently required.
•Rigorous studies exploring strategies to improve telemedicine accessibility to diverse population groups are warranted.

Background
Telemedicine services have been increasingly used to facilitate post-treatment cancer survivorship care, including improving access; monitoring health status, health behaviors, and symptom management; enhancing information exchange; and mitigating the costs of care delivery, especially since the COVID-19 pandemic. To inform guidance for the use of telemedicine in the post-COVID era, the aim of this overview of systematic reviews (SRs) was to evaluate the efficacy of, and survivor engagement in, telemedicine interventions in the post-treatment survivorship phase, and to consider implementation barriers and facilitators.

Methods
PubMed, Cochrane CENTRAL, CINAHL, Embase, and Web of Science databases were searched. SRs that examined the use of telemedicine in the post-treatment phase of cancer survivorship, published between January 2010 and April 2021, were included. Efficacy data were synthesized narratively. Implementation barriers and facilitators were synthesized using the Consolidated Framework for Implementation Research.

Results
Twenty-nine SRs were included. A substantive body of evidence found telemedicine to benefit the management of psychosocial and physical effects, particularly for improving fatigue and cognitive function. There was a lack of evidence on the use of telemedicine in the prevention and surveillance for recurrences and new cancers as well as management of chronic medical conditions. This overview highlights a range of diverse barriers and facilitators at the patient, health service, and system levels.

Conclusions
This review highlights the benefits of telemedicine in addressing psychosocial and physical effects, but not in other areas of post-treatment cancer survivorship care. This large review provides practical guidance for use of telemedicine in post-treatment survivorship care.

Impact and interest:

61 citations in Scopus
34 citations in Web of Science®
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 230135
Item Type: Contribution to Journal (Review article)
Refereed: Yes
ORCID iD:
Chan, R. J.orcid.org/0000-0003-0248-7046
Crichton, M.orcid.org/0000-0002-1273-5368
Hart, N. H.orcid.org/0000-0003-2794-0193
Additional Information: Funding Information: This work was supported by the National Health and Medical Research Council Investigator Grant [grant number APP1194051] to RJC. The funder had no role in the design of the study, interpretation of the data, or the writing of the manuscript.
Measurements or Duration: 19 pages
Keywords: cancer survivors, neoplasms, systematic review, telemedicine
DOI: 10.1016/j.annonc.2021.09.001
ISSN: 0923-7534
Pure ID: 108833349
Divisions: Current > Research Centres > Centre for Healthcare Transformation
Current > Research Centres > Cancer and Palliative Care Outcomes Centre
Current > QUT Faculties and Divisions > Faculty of Health
Current > Schools > School of Nursing
Funding Information: This work was supported by the National Health and Medical Research Council Investigator Grant [grant number APP1194051] to RJC. The funder had no role in the design of the study, interpretation of the data, or the writing of the manuscript.
Funding:
Copyright Owner: 2021 European Society for Medical Oncology
Copyright Statement: This work is covered by copyright. Unless the document is being made available under a Creative Commons Licence, you must assume that re-use is limited to personal use and that permission from the copyright owner must be obtained for all other uses. If the document is available under a Creative Commons License (or other specified license) then refer to the Licence for details of permitted re-use. It is a condition of access that users recognise and abide by the legal requirements associated with these rights. If you believe that this work infringes copyright please provide details by email to qut.copyright@qut.edu.au
Deposited On: 27 Apr 2022 02:27
Last Modified: 26 Jul 2024 15:15